220 results on '"Stranne J"'
Search Results
2. Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey
3. Correction: Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial
4. Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.
5. Fosfomycin versus Ciprofloxacin as transrectal prostatebiopsy antibiotic prophylaxis an open randomized controlled multicenter drug trial
6. Lymph swelling after radical prostatectomy and pelvic lymph node dissection
7. Baseline description of clinical characteristics and first postoperative data of the SPCG-15 population
8. Complications after transrectal ultrasound guided biopsies in screening for prostate cancer with PSA followed by MRI – results from the Göteborg prostate cancer screening 2 trial
9. The value of systematic biopsies in screening for prostate cancer with PSA followed by MRI – results from the GÖTEBORG prostate cancer screening 2 trial
10. Re: Urinary Incontinence and Erectile Dysfunction after Robotic versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial
11. Additional value of systematic biopsies for preoperative assessment in MRI-detected prostate cancer
12. Inguinal hernia is a common complication in lower midline incision surgery
13. Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy : a 20-year journey
14. Residual/recurrent disease and deaths at 6 years after open or robotic-assisted radical prostatectomy in the prospective, controlled trial LAPPRO
15. Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial
16. A1161 - Lymph swelling after radical prostatectomy and pelvic lymph node dissection
17. A0819 - Baseline description of clinical characteristics and first postoperative data of the SPCG-15 population
18. Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey
19. Multiparametric (mp) MRI or biparametric (bp) MRI when screening for prostate cancer (PC). Results from the Göteborg 2 randomized PC screening study (G2 study)
20. Prostate cancer risk after stop-age in men participating in a long-term screening program: Results from the Gothenburg randomized population-based prostate-cancer screening trial
21. SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
22. 235 - At what age should a PSA-based screening program start? 20-year results from the Göteborg randomized population-based prostate cancer screening study
23. SPCG-15 : a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
24. SPCG-15:a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
25. Erectile function and oncologic outcomes following open retropubic and robot-assisted radical prostatectomy: Results from the laparoscopic prostatectomy robot open trial
26. Features of prostate cancers detected by MRI in the PSA range 1.8-2.99: A report from the Gothenburg 2 prostate cancer screening study
27. Long term outcomes for men in a screening trial with an initial benign biopsy: A population-based cohort
28. Outcomes after deferred radical prostatectomy for men initially managed with active surveillance
29. At what age should a PSA-based screening program start? 20-year results from the Göteborg randomized population-based prostate cancer screening study
30. Outcomes and complications of different radical therapies: are we comparing apples with oranges?
31. 1138 - Multiparametric (mp) MRI or biparametric (bp) MRI when screening for prostate cancer (PC). Results from the Göteborg 2 randomized PC screening study (G2 study)
32. 1125 - Prostate cancer risk after stop-age in men participating in a long-term screening program: Results from the Gothenburg randomized population-based prostate-cancer screening trial
33. 87 18-year follow up of the Gothenburg randomized population-based prostate cancer screening trial
34. 444 Variation between experienced surgeons in oncological and functional outcome after prostatectomy. A comparison between open and robotic surgeons in the Swedish LAPPRO study
35. 486 - Features of prostate cancers detected by MRI in the PSA range 1.8-2.99: A report from the Gothenburg 2 prostate cancer screening study
36. 61 - Long term outcomes for men in a screening trial with an initial benign biopsy: A population-based cohort
37. 1034 An update on the outcome of men on active surveillance in the Gothenburg randomized population-based prostate cancer screening trial
38. 760 Role of magnetic resonance imaging in prostate cancer screening; results from a pilot study within the Gothenburg randomized screening trial
39. 798 - Outcomes after deferred radical prostatectomy for men initially managed with active surveillance
40. PE07: Short-term results after robot-assisted laparoscopic radical prostatectomy compared to open surgery
41. PYJ03: Prevalence and predictors of thromboembolic events in patients undergoing lymph node dissection during radical prostatectomy
42. 848 18-year follow-up from the Gothenburg randomised prostate cancer screening trial
43. 850 A comparison of the effectiveness of organised versus opportunistic screening measured as number need to invite (NNI) and number needed to diagnose (NND). Results from the Gothenburg randomised population-based prostate cancer screening trial
44. 808 Effects of surgeon variability on oncological and functional outcomes in a population-based setting
45. 1094 Outcome following surveillance of men with screen-detected prostate cancer. Results from the Gothenburg randomised population-based prostate cancer screening trial
46. 304 THE EFFECT OF AGE AND NUMBER OF SCREENING VISITS ON THE CUMULATIVE RISK OF PROSTATE CANCER. RESULTS FROM THE GOTHENBURG RANDOMISED SCREENING TRIAL
47. 26 RESULTS FROM THE GOTHENBURG RANDOMISED PROSTATE CANCER SCREENING TRIAL
48. 23 THE ABSENCE OF LUTS IN MEN WITH A PSA ≥ 3.0 NG/ ML IS AN INDEPENDENT RISK FACTOR FOR PROSTATE CANCER
49. 742 PSA DOUBLING TIME PREDICTS OUTCOME AFTER ACTIVE SURVEILLANCE IN SCREENING DETECTED PROSTATE CANCER
50. POD-10.07: Components of the Metabolic Syndrome Are Risk Factors for LUTS in the Swedish Male Population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.